Bhavin Mehta agreed to acquire 7.13% of stake in Kilitch Drugs (India) Limited (BSE:524500) from Mukund Mehta on April 11, 2022. After the acquisition Bhavin Mehta will held 19.98% of shares and Mukund Mehta will held 5.72% of shares in Kilitch Drugs (India) Limited. The transaction is expected to close on or after April 18, 2022.

Bhavin Mehta completed the acquisition of 7.13% of stake in Kilitch Drugs (India) Limited (BSE:524500) from Mukund Mehta on April 22, 2022.